Starpharma an innovative Australian biotechnology company, today announced the signing of a collaboration and license agreement with Genentech, a member of the Roche Group, to develop potential cancer therapies that leverage Starpharma’s proprietary DEP® drug delivery technology.

Minovia Therapeutics Ltd. a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases and combat age-related decline, announces that the U.S. Food and Drug Administration

VarmX, a biotech company developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has entered into a strategic collaboration with global biotechnology leader,

Raludotatug deruxtecan has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with platinum-resistant epithelial ovarian, primary peritoneal or fallopian tube cancers expressing CDH6 who have received prior treatment with bevacizumab.

Charles River Laboratories International, Inc. has recently announced two strategic collaborations across its contract development and manufacturing organization (CDMO), aimed at advancing novel

The pharmaceutical industry is implementing cutting-edge cleanroom technologies to enhance manufacturing efficiency and compliance.

A leading biotechnology firm announces a $75 million funding round to expand its contract research organization services.

Scipher Medicine, a pioneer in network-based and AI-driven precision immunology, today announced a strategic collaboration with Maxymune Therapeutics, a biotechnology company focused on research

A leading biotech firm has acquired a revolutionary gene editing technology to streamline drug development processes.

Lawmakers have introduced a bill designed to expedite clinical trial processes by enhancing regulatory frameworks.